The University of Michigan will use a new $3.6 million federal grant to study how pain and opioids after surgery impact people with opioid use disorder, how guidelines might be adjusted to address post-surgical pain and how to prevent opioid-related harms.
Ionis outlines Phase 3 data for rare disease drug, preps for another potential launch
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS